Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Determining Optimal Intervals for In-Person Visits During Video-Based Telemedicine Among Patients With Hypertension: Cluster Randomized Controlled Trial.
Nishizaki Y, Kuroki H, Ishii S, Ohtsu S, Watanabe C, Nishizawa H, Nagao M, Nojima M, Watanabe R, Sato D, Sato K, Kawata Y, Wada H, Toyoda G, Ohbayashi K. Nishizaki Y, et al. Among authors: watanabe c, watanabe r. JMIR Cardio. 2023 Jun 8;7:e45230. doi: 10.2196/45230. JMIR Cardio. 2023. PMID: 37161483 Free PMC article.
Dipeptidyl Peptidase-4 Inhibitor Reduces the Risk of Developing Hypertrophic Scars and Keloids following Median Sternotomy in Diabetic Patients: A Nationwide Retrospective Cohort Study Using the National Database of Health Insurance Claims of Japan.
Suwanai H, Watanabe R, Sato M, Odawara M, Matsumura H. Suwanai H, et al. Among authors: watanabe r. Plast Reconstr Surg. 2020 Jul;146(1):83-89. doi: 10.1097/PRS.0000000000006904. Plast Reconstr Surg. 2020. PMID: 32590649
Reply: Dipeptidyl Peptidase-4 Inhibitor Reduces the Risk of Developing Hypertrophic Scars and Keloids following Median Sternotomy in Diabetic Patients: A Nationwide Retrospective Cohort Study Using the National Database of Health Insurance Claims of Japan.
Suwanai H, Watanabe R, Matsumura H. Suwanai H, et al. Among authors: watanabe r. Plast Reconstr Surg. 2021 Jun 1;147(6):1068e-1069e. doi: 10.1097/PRS.0000000000007936. Plast Reconstr Surg. 2021. PMID: 33961591 No abstract available.
Open-label, multicenter, dose-titration study to determine the efficacy and safety of tolvaptan in Japanese patients with hyponatremia secondary to syndrome of inappropriate secretion of antidiuretic hormone.
Arima H, Goto K, Motozawa T, Mouri M, Watanabe R, Hirano T, Ishikawa SE. Arima H, et al. Among authors: watanabe r. Endocr J. 2021 Jan 28;68(1):17-29. doi: 10.1507/endocrj.EJ20-0216. Epub 2020 Aug 29. Endocr J. 2021. PMID: 32863282 Free article. Clinical Trial.
2,288 results